LivaNova (LIVN) Cash from Investing Activities Growth (1y) (2017 - 2026)
LivaNova (LIVN) Cash from Investing Activities Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -208.79% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -514.25% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -397.90% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -211.17% |
| 10 | LivaNova | 4.34 Bn | 3.76 Bn | 243.75 Mn | -37.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.18% |
| Dec 31, 2025 | -182.58% |
| Sep 30, 2025 | -24.50% |
| Jun 30, 2025 | 28.65% |
| Mar 31, 2025 | -67.03% |
| Dec 31, 2024 | 11.78% |
| Sep 30, 2024 | -84.21% |
| Jun 30, 2024 | -88.87% |
| Mar 31, 2024 | 44.59% |
| Dec 31, 2023 | -10.82% |
| Sep 30, 2023 | -72.42% |
| Jun 30, 2023 | 58.79% |
| Mar 31, 2023 | -109.49% |
| Dec 31, 2022 | -201.65% |
| Sep 30, 2022 | 5.65% |
| Jun 30, 2022 | -128.54% |
| Mar 31, 2022 | 44.39% |
| Dec 31, 2021 | 57.32% |
| Sep 30, 2021 | 42.09% |
| Jun 30, 2021 | 588.50% |